MGX
Metagenomi Inc.

787
Mkt Cap
$59.32M
Volume
196,523.00
52W High
$3.95
52W Low
$1.23
PE Ratio
-0.65
MGX Fundamentals
Price
$1.54
Prev Close
$1.58
Open
$1.57
50D MA
$1.68
Beta
1.04
Avg. Volume
377,379.50
EPS (Annual)
-$2.09
P/B
0.32
Rev/Employee
$258,886.14
Loading...
Loading...
Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
202

Frequently Asked Questions

What is Market Cap of Metagenomi Therapeutics Inc.?
What is the 52-week high for Metagenomi Therapeutics Inc.?
What is the 52-week low for Metagenomi Therapeutics Inc.?
What is Metagenomi Therapeutics Inc. stock price today?
What was Metagenomi Therapeutics Inc. stock price yesterday?
What is the PE ratio of Metagenomi Therapeutics Inc.?
What is the Price-to-Book ratio of Metagenomi Therapeutics Inc.?
What is the 50-day moving average of Metagenomi Therapeutics Inc.?
How many employess does Metagenomi Therapeutics Inc. has?

Latest MGX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.